Nifty

:

24056.00

Sensex

:

77100.47

34.35 (0.14%)
109.25 (0.14%)

Login

Nifty
Sensex

:
:

24056.00
77100.47

34.35 (0.14%)
109.25 (0.14%)

Unichem Laboratories Ltd.

Pharmaceuticals & Drugs - Global

Rating :

53/99

BSE: 506690 | NSE: UNICHEMLAB

Watchlist

NSE BSE

433.00

25-Jun-2026

Open
High
Low
Previous Close

430.4
439.45
425.5
433.55

Volume
Traded Value (lacs)
52 Week High
52 Week Low

86322
37280466.85
657.95
278.2

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

3,044.34
12.04
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

2,839.79
N/A
1.13

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

4.71
11.31
16.27

EBITDA CAGR (%)

10 Years
5 Years
3 Years

4.92
23.79
-

PAT CAGR (%)

10 Years
5 Years
3 Years

2.44
32.00
-

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

1.00
1.24
1.51

EV:EBITDA (Average)

8 Years
5 Years
3 Years

24.44
19.27
29.01

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 356.24 461.24 -22.76% 314.90 447.83 -29.68% 356.90 436.88 -18.31% 384.25 389.75 -1.41%
Expenses 343.75 386.26 -11.01% 313.51 373.62 -16.09% 349.20 372.38 -6.22% 358.51 349.56 2.56%
EBITDA 12.49 74.98 -83.34% 1.39 74.21 -98.13% 7.70 64.50 -88.06% 25.74 40.19 -35.95%
EBIDTM 3.51% 16.26% 0.44% 16.57% 2.16% 14.76% 6.70% 10.31%
Other Income 22.22 6.05 267.27% 15.03 18.93 -20.60% 21.40 7.08 202.26% 4.25 8.77 -51.54%
Interest 4.09 1.53 167.32% 2.10 2.89 -27.34% 3.68 1.82 102.20% 1.93 1.38 39.86%
Depreciation 28.97 27.47 5.46% 30.02 28.45 5.52% 30.11 26.39 14.10% 29.93 26.10 14.67%
PBT -10.71 56.03 - 259.82 61.80 320.42% -37.83 43.37 - -1.87 21.48 -
Tax 4.68 4.81 -2.70% 43.71 14.91 193.16% 2.10 0.00 0 -0.02 0.00 -
PAT -15.39 51.22 - 216.11 46.89 360.89% -39.93 43.37 - -1.85 21.48 -
PATM -4.32% 11.10% 68.63% 10.47% -11.19% 9.93% -0.48% 5.51%
EPS -2.19 7.28 - 30.70 6.66 360.96% -5.67 6.16 - -0.26 3.05 -

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 575.12 587.18 -2.05% 521.17 533.09 -2.24% 578.96 507.36 14.11% 526.60 483.34 8.95%
Expenses 527.44 503.48 4.76% 476.39 447.57 6.44% 512.78 451.87 13.48% 504.11 443.19 13.75%
EBITDA 47.68 83.70 -43.03% 44.78 85.52 -47.64% 66.18 55.49 19.26% 22.49 40.15 -43.99%
EBIDTM 8.29% 14.25% 8.59% 16.04% 11.43% 10.94% 4.27% 8.31%
Other Income 23.47 9.25 153.73% 11.80 13.62 -13.36% 20.97 8.69 141.31% 6.82 3.76 81.38%
Interest 9.39 5.46 71.98% 7.42 6.75 9.93% 8.24 4.79 72.03% 6.54 4.03 62.28%
Depreciation 30.61 29.69 3.10% 31.25 30.54 2.32% 31.47 32.26 -2.45% 31.79 32.07 -0.87%
PBT 18.79 57.80 -67.49% 293.43 61.85 374.42% -10.82 27.13 - -9.02 7.81 -
Tax 7.88 4.83 63.15% 29.14 4.00 628.50% 1.07 2.50 -57.20% 1.45 5.74 -74.74%
PAT 10.91 52.97 -79.40% 264.29 57.85 356.85% -11.89 24.63 - -10.47 2.07 -
PATM 1.90% 9.02% 50.71% 10.85% -2.05% 4.85% -1.99% 0.43%
EPS 1.55 7.52 -79.39% 37.54 8.22 356.69% -1.69 3.50 - -1.49 0.29 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 1,412.29 1,735.70 1,442.16 1,072.43 942.93 1,123.97 904.44 967.74 666.08 576.07 1,220.52 Net Sales Growth -18.63% 20.35% 34.48% 13.73% -16.11% 24.27% -6.54% 45.29% 15.62% -52.80% Cost Of Goods Sold 665.36 685.34 592.47 455.40 324.56 359.33 311.23 339.36 274.57 188.07 395.62 Gross Profit 746.93 1,050.36 849.69 617.03 618.37 764.64 593.21 628.37 391.51 387.99 824.90 GP Margin 52.89% 60.52% 58.92% 57.54% 65.58% 68.03% 65.59% 64.93% 58.78% 67.35% 67.59% Total Expenditure 1,364.97 1,481.82 1,391.25 1,165.35 986.48 1,028.51 995.05 1,028.53 802.30 634.09 1,078.24 Power & Fuel Cost - 106.63 105.64 101.41 77.12 67.95 72.14 75.43 48.26 40.76 37.34 % Of Sales - 6.14% 7.33% 9.46% 8.18% 6.05% 7.98% 7.79% 7.25% 7.08% 3.06% Employee Cost - 287.51 283.15 270.86 250.79 234.04 205.16 176.76 146.54 117.68 209.60 % Of Sales - 16.56% 19.63% 25.26% 26.60% 20.82% 22.68% 18.27% 22.00% 20.43% 17.17% Manufacturing Exp. - 238.45 222.94 189.07 189.10 207.65 220.58 230.34 115.50 90.53 132.41 % Of Sales - 13.74% 15.46% 17.63% 20.05% 18.47% 24.39% 23.80% 17.34% 15.72% 10.85% General & Admin Exp. - 89.97 93.26 88.02 82.51 94.82 115.58 100.19 154.32 103.52 145.52 % Of Sales - 5.18% 6.47% 8.21% 8.75% 8.44% 12.78% 10.35% 23.17% 17.97% 11.92% Selling & Distn. Exp. - 73.92 93.79 56.88 53.45 61.44 66.88 87.17 52.96 65.40 132.40 % Of Sales - 4.26% 6.50% 5.30% 5.67% 5.47% 7.39% 9.01% 7.95% 11.35% 10.85% Miscellaneous Exp. - 0.00 0.00 3.70 8.95 3.28 3.48 19.29 10.15 28.13 132.40 % Of Sales - 0% 0% 0.35% 0.95% 0.29% 0.38% 1.99% 1.52% 4.88% 2.08% EBITDA 47.32 253.88 50.91 -92.92 -43.55 95.46 -90.61 -60.79 -136.22 -58.02 142.28 EBITDA Margin 3.35% 14.63% 3.53% -8.66% -4.62% 8.49% -10.02% -6.28% -20.45% -10.07% 11.66% Other Income 62.90 40.83 30.39 41.85 42.07 47.37 99.17 101.54 62.89 7.19 22.71 Interest 11.80 7.62 10.42 9.38 2.07 1.30 1.28 0.62 3.17 2.00 2.29 Depreciation 119.03 108.41 105.45 105.98 83.19 75.89 71.09 61.71 45.04 39.41 34.99 PBT 209.41 178.68 -34.57 -166.43 -86.75 65.65 -63.81 -21.58 -121.55 -92.23 127.70 Tax 50.47 19.72 0.00 20.61 -31.32 11.56 -7.50 -28.62 -0.14 -16.70 23.69 Tax Rate 24.10% 10.79% 0.00% -7.38% 36.10% 17.61% 11.75% 132.62% 0.12% 18.11% 19.08% PAT 158.94 162.96 -92.18 -299.70 -55.43 54.08 -56.32 7.04 -121.41 -75.53 100.48 PAT before Minority Interest 158.94 162.96 -92.18 -299.70 -55.43 54.08 -56.32 7.04 -121.41 -75.53 100.48 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 11.25% 9.39% -6.39% -27.95% -5.88% 4.81% -6.23% 0.73% -18.23% -13.11% 8.23% PAT Growth -2.47% - - - - - - - - - EPS 22.58 23.15 -13.09 -42.57 -7.87 7.68 -8.00 1.00 -17.25 -10.73 14.27

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 2,201.85 2,110.97 1,785.11 1,343.02 1,269.83 1,235.14 1,103.71 1,180.05 814.59 697.71 1,332.65 Net Sales Growth 4.31% 18.25% 32.92% 5.76% 2.81% 11.91% -6.47% 44.86% 16.75% -47.64% Cost Of Goods Sold 1,020.55 751.11 637.70 482.45 356.91 302.14 308.63 364.19 274.97 188.77 386.97 Gross Profit 1,181.30 1,359.86 1,147.41 860.57 912.92 933.00 795.08 815.85 539.62 508.94 945.67 GP Margin 53.65% 64.42% 64.28% 64.08% 71.89% 75.54% 72.04% 69.14% 66.24% 72.94% 70.96% Total Expenditure 2,020.72 1,846.11 1,698.23 1,388.58 1,197.04 1,144.03 1,154.53 1,263.54 946.48 739.11 1,168.77 Power & Fuel Cost - 108.16 107.14 102.84 78.05 68.89 73.02 76.39 49.23 41.62 38.25 % Of Sales - 5.12% 6.00% 7.66% 6.15% 5.58% 6.62% 6.47% 6.04% 5.97% 2.87% Employee Cost - 402.21 403.20 356.41 330.49 306.97 273.28 238.52 200.64 169.04 255.92 % Of Sales - 19.05% 22.59% 26.54% 26.03% 24.85% 24.76% 20.21% 24.63% 24.23% 19.20% Manufacturing Exp. - 242.87 227.83 194.60 193.21 215.73 232.08 242.23 125.30 103.70 150.54 % Of Sales - 11.51% 12.76% 14.49% 15.22% 17.47% 21.03% 20.53% 15.38% 14.86% 11.30% General & Admin Exp. - 139.75 138.44 119.02 109.60 123.98 147.90 128.70 182.80 126.15 167.66 % Of Sales - 6.62% 7.76% 8.86% 8.63% 10.04% 13.40% 10.91% 22.44% 18.08% 12.58% Selling & Distn. Exp. - 202.01 183.92 129.56 120.68 122.52 116.12 197.24 108.38 107.77 166.84 % Of Sales - 9.57% 10.30% 9.65% 9.50% 9.92% 10.52% 16.71% 13.30% 15.45% 12.52% Miscellaneous Exp. - 0.00 0.00 3.70 8.11 3.81 3.50 16.26 5.16 2.06 166.84 % Of Sales - 0% 0% 0.28% 0.64% 0.31% 0.32% 1.38% 0.63% 0.30% 0.19% EBITDA 181.13 264.86 86.88 -45.56 72.79 91.11 -50.82 -83.49 -131.89 -41.40 163.88 EBITDA Margin 8.23% 12.55% 4.87% -3.39% 5.73% 7.38% -4.60% -7.08% -16.19% -5.93% 12.30% Other Income 63.06 35.32 31.59 38.52 47.51 50.19 91.31 98.41 60.88 5.50 19.11 Interest 31.59 21.03 22.66 17.31 6.11 5.12 7.85 7.52 8.01 3.36 2.90 Depreciation 125.12 124.56 123.16 113.44 91.17 84.36 81.67 67.37 50.51 43.52 38.79 PBT 292.38 154.59 -27.35 -137.80 23.03 51.82 -49.02 -59.97 -129.53 -82.76 141.31 Tax 39.54 17.07 8.80 25.86 -11.09 17.15 11.97 -34.35 3.34 -11.85 29.30 Tax Rate 13.52% 11.04% -10.36% -14.66% -48.15% 33.10% -24.42% 57.28% -2.58% 14.32% 21.27% PAT 252.84 137.52 -93.76 -202.23 33.06 34.32 -60.18 -25.56 -133.10 -70.72 108.11 PAT before Minority Interest 252.84 137.52 -93.76 -202.23 33.06 34.32 -60.18 -25.56 -133.10 -70.72 108.11 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 11.48% 6.51% -5.25% -15.06% 2.60% 2.78% -5.45% -2.17% -16.34% -10.14% 8.11% PAT Growth 83.86% - - - -3.67% - - - - - EPS 35.91 19.53 -13.32 -28.73 4.70 4.88 -8.55 -3.63 -18.91 -10.05 15.36

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 2,459.75 2,294.63 2,384.27 2,672.04 2,697.33 2,647.18 2,731.93 2,761.67 1,130.73 1,027.15 Share Capital 14.08 14.08 14.08 14.08 14.08 14.08 14.08 14.07 18.18 18.17 Total Reserves 2,440.55 2,277.49 2,358.14 2,647.28 2,675.50 2,628.28 2,714.02 2,747.01 1,111.11 1,007.83 Non-Current Liabilities 129.93 81.13 113.21 139.63 50.27 29.68 26.79 50.07 70.40 63.66 Secured Loans 60.81 38.22 63.65 89.01 0.00 0.00 0.00 0.33 0.44 0.46 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 37.86 35.80 41.91 39.96 30.41 23.51 14.60 10.76 25.33 12.58 Current Liabilities 519.53 465.75 388.66 310.42 371.45 348.27 271.50 295.88 301.81 282.61 Trade Payables 261.65 249.49 244.47 157.08 188.57 208.22 192.69 211.51 228.28 189.63 Other Current Liabilities 98.87 80.41 119.82 125.82 168.06 115.02 67.56 60.40 56.73 47.43 Short Term Borrowings 21.37 0.00 12.36 11.43 0.00 15.21 0.00 0.00 0.55 7.90 Short Term Provisions 137.64 135.85 12.01 16.09 14.83 9.81 11.25 23.97 16.25 37.65 Total Liabilities 3,109.21 2,841.51 2,886.14 3,122.09 3,119.05 3,025.13 3,030.22 3,107.62 1,502.94 1,373.42 Net Block 1,274.69 1,164.94 1,235.94 963.12 846.23 824.94 785.16 551.12 464.17 381.20 Gross Block 1,925.53 1,718.29 1,690.90 1,323.61 1,128.33 1,037.52 939.38 655.08 535.64 414.65 Accumulated Depreciation 650.84 553.35 454.95 360.49 282.11 212.58 154.22 103.96 71.47 33.45 Non Current Assets 1,533.35 1,454.22 1,589.96 1,748.12 1,813.69 1,520.42 1,177.12 895.56 815.69 744.42 Capital Work in Progress 31.03 122.36 147.82 494.18 567.73 330.84 90.25 235.53 247.26 232.65 Non Current Investment 45.62 42.74 38.98 126.22 283.99 249.17 241.70 83.25 81.37 102.52 Long Term Loans & Adv. 182.01 124.18 167.22 164.61 112.21 111.88 56.36 21.94 19.11 28.05 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 1,566.34 1,383.94 1,292.76 1,370.49 1,305.37 1,504.71 1,852.23 2,212.05 687.25 629.00 Current Investments 0.00 1.34 1.54 263.58 236.43 419.10 800.75 895.55 8.00 8.04 Inventories 584.06 500.53 480.19 460.69 386.12 315.57 274.18 207.76 253.98 200.66 Sundry Debtors 748.14 558.41 472.08 380.84 360.48 323.10 331.35 231.74 296.49 264.73 Cash & Bank 88.63 129.06 157.28 99.03 57.59 205.37 191.03 673.61 10.16 10.94 Other Current Assets 145.51 23.93 25.93 28.86 264.75 241.57 254.93 203.39 118.61 144.63 Short Term Loans & Adv. 109.53 170.67 155.75 137.48 213.34 188.60 198.14 148.82 100.55 121.55 Net Current Assets 1,046.81 918.19 904.10 1,060.07 933.91 1,156.45 1,580.72 1,916.17 385.44 346.38 Total Assets 3,099.69 2,838.16 2,882.72 3,118.61 3,119.06 3,025.13 3,029.35 3,107.61 1,502.94 1,373.42

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 2,450.59 2,438.30 2,435.30 2,618.41 2,556.83 2,531.35 2,619.91 2,680.08 1,063.62 954.33 Share Capital 14.08 14.08 14.08 14.08 14.08 14.08 14.08 14.07 18.18 18.17 Total Reserves 2,431.39 2,421.16 2,409.18 2,593.65 2,535.00 2,512.44 2,601.99 2,665.42 1,044.00 935.01 Non-Current Liabilities 98.72 92.27 108.03 143.88 49.16 43.72 10.10 46.46 64.49 76.02 Secured Loans 60.81 38.22 63.65 89.01 0.00 0.00 0.00 0.33 0.44 22.98 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 37.86 35.80 41.91 39.96 30.41 23.51 14.60 10.76 25.33 12.58 Current Liabilities 991.97 737.60 639.60 552.13 505.76 566.73 502.92 463.51 392.62 275.09 Trade Payables 402.55 351.26 290.69 183.19 210.08 250.22 221.41 226.23 210.73 163.95 Other Current Liabilities 107.15 93.01 128.34 135.06 176.97 122.04 68.45 63.03 68.01 60.56 Short Term Borrowings 340.29 155.27 208.08 215.69 100.63 184.03 199.67 150.29 97.62 12.93 Short Term Provisions 141.98 138.06 12.50 18.19 18.09 10.44 13.39 23.97 16.25 37.65 Total Liabilities 3,541.28 3,268.17 3,182.93 3,314.42 3,111.75 3,141.80 3,132.93 3,190.05 1,520.73 1,305.44 Net Block 1,299.57 1,252.40 1,256.66 990.03 880.42 866.06 806.29 574.45 487.22 402.60 Gross Block 1,993.53 1,919.54 1,750.29 1,379.74 1,193.56 1,098.27 975.96 689.74 561.37 439.53 Accumulated Depreciation 693.96 667.14 493.63 389.70 313.14 232.21 169.67 115.29 74.15 36.92 Non Current Assets 1,505.67 1,521.50 1,591.06 1,666.02 1,734.44 1,455.33 1,093.64 853.59 772.27 673.34 Capital Work in Progress 30.67 122.71 147.45 493.81 567.50 330.47 92.39 238.15 249.98 237.13 Non Current Investment 0.02 0.02 0.16 0.28 155.59 130.78 125.54 5.48 5.72 5.54 Long Term Loans & Adv. 150.61 124.92 168.07 165.59 112.89 112.90 56.37 24.05 20.40 28.05 Other Non Current Assets 24.80 21.45 18.72 16.30 14.52 11.52 9.39 7.74 5.17 0.00 Current Assets 2,029.47 1,743.32 1,588.47 1,644.92 1,377.32 1,686.47 2,038.41 2,336.47 748.46 632.11 Current Investments 0.00 1.34 1.54 263.58 236.43 419.10 800.75 895.55 8.00 8.04 Inventories 988.74 736.26 625.23 600.22 538.34 396.54 338.66 272.86 281.71 230.57 Sundry Debtors 778.81 642.31 588.62 495.43 250.27 390.14 436.05 276.92 315.32 220.09 Cash & Bank 117.63 158.16 185.36 114.10 82.45 233.81 200.99 681.46 16.14 20.13 Other Current Assets 144.29 29.79 31.31 33.47 269.83 246.88 261.96 209.67 127.29 153.28 Short Term Loans & Adv. 101.58 175.46 156.40 138.12 213.83 188.87 200.78 148.85 100.72 122.77 Net Current Assets 1,037.50 1,005.72 948.86 1,092.80 871.56 1,119.74 1,535.50 1,872.95 355.84 357.02 Total Assets 3,535.14 3,264.82 3,179.53 3,310.94 3,111.76 3,141.80 3,132.05 3,190.06 1,520.73 1,305.45

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 72.29 -41.57 -117.33 -158.31 -32.61 -41.84 -251.30 -66.25 140.78 116.58 PBT 182.68 -92.18 -279.09 -86.75 65.65 -63.81 -19.11 3,249.34 131.60 124.17 Adjustment 107.30 165.38 203.30 72.20 49.68 -6.17 -7.08 -3,214.36 72.37 56.10 Changes in Working Capital -217.41 -114.62 -41.45 -147.82 -147.63 25.49 -217.91 -103.24 -35.89 -32.73 Cash after chg. in Working capital 72.57 -41.42 -117.24 -162.37 -32.30 -44.49 -244.10 -68.27 168.08 147.55 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.28 -0.15 -0.09 4.06 -0.31 2.65 -7.20 2.01 -27.30 -30.97 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -132.07 53.24 202.50 106.31 -80.39 -35.59 -322.63 1,648.30 -131.91 -86.73 Net Fixed Assets -115.91 -1.93 -20.93 -121.73 -327.70 -338.73 -139.02 -107.71 -135.60 154.89 Net Investments -1.54 -3.56 349.28 130.62 147.85 374.18 -63.65 -889.43 21.19 42.09 Others -14.62 58.73 -125.85 97.42 99.46 -71.04 -119.96 2,645.44 -17.50 -283.71 Cash from Financing Activity -4.61 -48.06 -61.76 95.80 -45.07 -21.02 -44.89 -929.51 -8.95 -38.63 Net Cash Inflow / Outflow -64.39 -36.39 23.41 43.81 -158.07 -98.45 -618.82 652.53 -0.08 -8.77 Opening Cash & Equivalents 125.65 155.67 94.13 52.60 203.08 188.66 660.31 7.77 7.86 19.71 Closing Cash & Equivalent 60.58 125.65 155.67 94.13 52.60 203.08 188.66 660.31 7.77 10.94

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity -7.02 14.00 -85.09 -259.61 32.98 19.82 -327.77 -112.34 68.19 111.91 PBT 154.59 -84.96 -176.36 21.97 51.48 -48.21 -57.44 3,241.14 141.25 137.68 Adjustment 148.70 197.32 132.84 80.46 65.65 18.79 6.80 -3,207.66 53.31 39.65 Changes in Working Capital -293.89 -91.99 -29.36 -354.43 -69.78 53.58 -264.94 -146.67 -98.65 -34.16 Cash after chg. in Working capital 9.40 20.37 -72.88 -252.00 47.35 24.15 -315.57 -113.20 95.91 143.16 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -16.42 -6.37 -12.21 -7.62 -14.36 -4.34 -12.20 0.86 -27.72 -31.25 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -241.23 50.40 202.81 102.40 -73.56 -35.91 -286.01 1,648.33 -127.87 -85.33 Net Fixed Assets -115.91 -1.93 -20.93 -121.73 -327.70 -338.73 -139.02 -107.71 -135.60 154.89 Net Investments -1.54 -3.56 349.28 130.62 147.85 374.18 -63.65 -889.43 21.19 42.09 Others -123.78 55.89 -125.54 93.51 106.29 -71.36 -83.34 2,645.47 -13.46 -282.31 Cash from Financing Activity 183.76 -106.31 -81.30 191.23 -121.07 -62.30 -2.42 -881.13 59.23 -33.42 Net Cash Inflow / Outflow -64.49 -41.91 36.42 34.01 -161.65 -78.40 -616.19 654.86 -0.46 -6.84 Opening Cash & Equivalents 154.75 183.75 109.20 77.46 231.52 197.05 666.07 11.21 11.67 26.96 Closing Cash & Equivalent 89.58 154.75 183.75 109.20 77.46 231.52 197.05 666.07 11.21 20.13

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 348.67 325.51 336.94 378.00 382.01 375.30 387.60 392.55 124.27 112.94 ROA 5.48% -3.22% -9.98% -1.78% 1.76% -1.86% 0.29% 110.90% 7.22% 7.74% ROE 6.87% -3.95% -11.91% -2.07% 2.03% -2.10% 0.32% 131.43% 9.64% 10.19% ROCE 7.72% -3.38% -10.21% -3.08% 2.50% -2.32% -0.67% 167.06% 12.33% 12.75% Fixed Asset Turnover 0.95 0.85 0.71 0.77 1.04 0.92 1.22 2.07 2.99 2.25 Receivable days 137.38 130.40 145.14 143.48 110.99 132.06 105.30 78.26 72.16 69.53 Inventory Days 114.04 124.11 160.11 163.90 113.93 119.00 90.13 68.41 58.46 57.16 Payable days 136.11 152.16 160.92 194.36 201.52 82.50 82.64 118.77 140.05 63.62 Cash Conversion Cycle 115.30 102.35 144.34 113.02 23.40 168.55 112.80 27.91 -9.43 63.06 Total Debt/Equity 0.05 0.03 0.04 0.05 0.00 0.01 0.00 0.00 0.00 0.01 Interest Cover 24.97 -7.85 -28.75 -40.82 51.47 -48.78 -29.97 1027.03 66.88 55.19

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 347.37 345.91 344.18 370.38 362.05 358.85 371.69 380.95 116.88 104.93 ROA 4.04% -2.91% -6.22% 1.03% 1.11% -1.94% -0.75% 108.06% 7.68% 8.82% ROE 5.64% -3.86% -8.04% 1.28% 1.37% -2.37% -0.90% 136.04% 10.77% 11.92% ROCE 6.34% -2.31% -5.60% 1.00% 2.12% -1.49% -1.77% 162.77% 13.42% 14.97% Fixed Asset Turnover 1.08 0.97 0.86 0.99 1.08 1.06 1.43 2.21 3.08 2.32 Receivable days 122.86 125.84 147.31 107.17 94.63 136.61 109.51 78.30 63.41 55.72 Inventory Days 149.13 139.19 166.52 163.63 138.14 121.57 93.93 73.33 60.67 59.32 Payable days 183.16 183.72 179.25 201.09 278.03 76.39 73.41 94.97 104.25 52.00 Cash Conversion Cycle 88.84 81.32 134.58 69.71 -45.27 181.78 130.03 56.65 19.82 63.05 Total Debt/Equity 0.18 0.09 0.12 0.13 0.04 0.07 0.08 0.06 0.09 0.04 Interest Cover 8.35 -2.75 -9.19 4.60 11.12 -5.25 -6.64 405.79 43.00 48.57

Top Investors:

hdfc small cap fund

dsp healthcare fund

investor education and protection fund authority ministry of corporate affairs

Annual Reports:

News Update:

Unichem Lab - Quarterly Results
23rd May 2026, 00:00 AM

Read More
Unichem Laboratories’ arm recalls 500-count bottles of Buspirone Hydrochloride Tablets
13th Apr 2026, 10:59 AM

Unichem Pharmaceuticals (USA) has recalled the product after out-of-specification assay result identified at the 12-month long-term stability time point
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback